Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

2.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.7K
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.2K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

405
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
405
Drug Discovery: Overview01:26

Drug Discovery: Overview

7.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.4K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

491
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
491
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

114
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
114

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence Map Analysis on Randomized Controlled Trials: Chinese Patent Medicines and Classic Traditional Chinese Medicine Prescriptions.

Journal of evidence-based medicine·2026
Same author

Ultrastructural morphometry and genetic divergence of spermatozoa in two morphologically similar Triplophysa species.

Tissue & cell·2026
Same author

Development of a core outcome set for traditional Chinese medicine for atrial fibrillation.

Frontiers in pharmacology·2026
Same author

[Development and Application of Multi-RevRobot for the Translation of Clinical Evidence of Traditional Chinese Medicine].

Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation·2026
Same author

Synergistic heat-moisture-ultrasound modification enhances starch-glutelin interactions: A pathway to tailored physicochemical properties and reduced digestibility in purple rice blends.

Carbohydrate polymers·2025
Same author

The pharmacology and mechanism of action of <i>Monascus purpureus</i> Went: a scoping review.

Frontiers in pharmacology·2025

Related Experiment Video

Updated: May 28, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.4K

Patient-Focused Drug Development and Real World Study.

Haiyin Hu1,2, Hui Wang1, Lin Ang3

  • 1Evidence Base Medicine Center, Tianjin University of Traditional Chinese Medicine, Tianjin, PR China.

Integrative Medicine Research
|February 12, 2025
PubMed
Summary

Patient-focused drug development (PFDD) and real-world studies (RWS) offer distinct advantages. Combining PFDD principles with RWS methods can innovate research, optimize clinical trials, and maximize patient benefits in drug development.

Keywords:
Patient demandPatient-focused drug developmentReal-world studyResearch method

More Related Videos

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

4.8K
Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis
12:41

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis

Published on: December 23, 2022

4.7K

Related Experiment Videos

Last Updated: May 28, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.4K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

4.8K
Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis
12:41

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis

Published on: December 23, 2022

4.7K

Area of Science:

  • Medical research methodology
  • Clinical trial design
  • Drug development

Background:

  • Patient-focused drug development (PFDD) is crucial for advancing medicine.
  • Both PFDD and real-world studies (RWS) are gaining significant interest due to their unique advantages.
  • Optimizing clinical research design and implementation is a key goal.

Purpose of the Study:

  • To innovate research methods in drug development.
  • To optimize the design and implementation of clinical research.
  • To explore the potential of a "patient-focused RWS" research model.

Main Methods:

  • Comparative analysis of PFDD and RWS clinical trials.
  • Evaluation of PICO elements, research teams, and data acquisition.
  • Assessment of the feasibility and significance of integrating PFDD and RWS.

Main Results:

  • PFDD prioritizes patient needs, willingness, and satisfaction, collecting patient experience data.
  • RWS emphasizes research environment facticity and broad patient sources, addressing extrapolation and applicability.
  • Both PFDD and RWS ultimately benefit patients through their respective focuses.

Conclusions:

  • Integrating PFDD concepts with RWS methods maximizes patient benefits.
  • A combined PFDD-RWS model can facilitate drug development and dissemination.
  • This approach offers innovative research methods applicable across various fields.